FO
LUMO

FT Options’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

FT Options’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$14K Buy
+2,222
New +$170K 0.02% 180
2016
Q3 		– Sell
-2,433
Closed -$1.29M – 460
2016
Q2 		$1.29M Buy
2,433
+211
+9% +$26.2K 1.11% 19
2016
Q1 		$1.16M Sell
2,222
-5,756
-72% -$1.17M 1.22% 20
2015
Q4 		$920K Buy
+7,978
New +$2.6M 0.68% 43

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

FT Options's LUMO Position: Q3 2017 in Review

FT Options opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017: 2,311 shares worth $212K. The stake represents 0.32% of the portfolio and ranks #62 among its holdings. This is a return to the name: FT Options previously reported a position in LUMO as recently as Q1 2017.

FT Options first reported a position in LUMO in Q4 2015 and has held it in 6 quarters since. The position peaked at $1.71M in Q4 2015. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

  • FT Options held 2,311 shares of Lumos Pharma, Inc. Common Stock worth $212K as of Q3 2017.
  • Lumos Pharma, Inc. Common Stock was a new FT Options position in Q3 2017.
  • Lumos Pharma, Inc. Common Stock made up 0.32% of FT Options's portfolio in Q3 2017, its #62 holding.
  • FT Options first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2015 and has held it in 6 quarters since.
  • FT Options's Lumos Pharma, Inc. Common Stock position peaked at $1.71M in Q4 2015.
  • 126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.